Role of TP53 polymorphisms in sub-Saharan mucosal cancers

Role of TP53 polymorphisms in sub-Saharan mucosal cancers

Bibliographic Details
Main Authors:	Buonaguro Luigi, Tornesello MariaLina, Buonaguro Franco M
Format:	Article
Language:	English
Published:	BMC 2010-10-01
Series:	Infectious Agents and Cancer

Similar Items

<it>TP</it>53 and <it>MDM2 </it>gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
by: Buonaguro Franco M, et al.
Published: (2011-08-01)

HPV monitoring in kidney transplanted patients
by: Buonaguro Franco M, et al.
Published: (2012-04-01)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
by: Maria Lina Tornesello, et al.
Published: (2018-06-01)

Use of adjuvants for immunotherapy
by: Luisa Circelli, et al.
Published: (2017-08-01)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
by: Andrea Cerasuolo, et al.
Published: (2020-06-01)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2020-04-01)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2022-02-01)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
by: Anna Lucia Tornesello, et al.
Published: (2017-08-01)

Human Papillomavirus and Cancers
by: Maria Lina Tornesello, et al.
Published: (2020-12-01)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
by: Luigi Buonaguro, et al.
Published: (2020-05-01)

Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
by: Noemy Starita, et al.
Published: (2018-03-01)

Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
by: Anna Lucia Tornesello, et al.
Published: (2020-06-01)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
by: Luisa Circelli, et al.
Published: (2015-07-01)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
by: Tornesello Maria, et al.
Published: (2007-05-01)

The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer
by: Maria Lina Tornesello, et al.
Published: (2020-02-01)

Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
by: Maria Lina Tornesello, et al.
Published: (2023-11-01)

Molecular mimicry and cancer vaccine development
by: Maria Tagliamonte, et al.
Published: (2023-04-01)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
by: Visciano Maria Luisa, et al.
Published: (2012-01-01)

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma
by: Buonaguro Luigi, et al.
Published: (2009-10-01)

Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
by: Antonella Borrelli, et al.
Published: (2018-01-01)

Human papillomavirus infection and cervical neoplasia among migrant women living in Italy
by: Maria Lina eTornesello, et al.
Published: (2014-02-01)

The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
by: Maria Lina Tornesello, et al.
Published: (2022-10-01)

The Role of circRNAs in Human Papillomavirus (HPV)-Associated Cancers
by: Patrizia Bonelli, et al.
Published: (2021-03-01)

Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy
by: Piccoli Roberto, et al.
Published: (2007-01-01)

Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?
by: Paolo Giorgi-Rossi, et al.
Published: (2024-04-01)

Structured particles for antigen presentation
by: Lewis GK, et al.
Published: (2006-12-01)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
by: Concetta Ragone, et al.
Published: (2022-07-01)

HIV p24 as scaffold for presenting conformational HIV Env antigens.
by: Maria Tagliamonte, et al.
Published: (2012-01-01)

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
by: Francesca Pezzuto, et al.
Published: (2021-07-01)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
by: Buonaguro FM, et al.
Published: (2009-10-01)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
by: Angela Mauriello, et al.
Published: (2019-11-01)

Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
by: Valeria De Giorgi, et al.
Published: (2013-01-01)

Solid Phase Formylation of N-Terminus Peptides
by: Anna Lucia Tornesello, et al.
Published: (2016-06-01)

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation
by: Marincola Francesco M, et al.
Published: (2005-12-01)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
by: Carmen Manolio, et al.
Published: (2022-10-01)

Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma
by: Noemy Starita, et al.
Published: (2017-06-01)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
by: Angela Mauriello, et al.
Published: (2021-12-01)

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
by: Buonaguro L, et al.
Published: (2009-10-01)

TP53 rs1042522 polymorphism and early-onset breast cancer
by: Irmak Icen-Taskin, et al.
Published: (2020-01-01)

Peptide-based vaccine for cancer therapies
by: Luigi Buonaguro, et al.
Published: (2023-08-01)